尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Furey Raymond J.. Officer active across 2 companies, notably RIGEL PHARMACEUTICALS INC. Aggregated, 9 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €29k. History available since 23 January 2024. The latest transaction was disclosed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Furey Raymond J. has 8 filings in total. Across the 8 sampled recent filings, the recorded volumes are EUR 0 of buys and EUR 29333 of sells, over the period from 2016-01-05 to 2026-02-19. He is associated with RIGEL PHARMACEUTICALS INC as EVP, GC, CCO & Corp Sec, and with Mallinckrodt plc as Sr. VP & Chief Compliance Ofcr.